Novel enhancers linked to Parkinson’s and schizophrenia
A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.
An international collaboration of researchers led by Masahito Yoshihara at Chiba University (Japan) has identified novel transcriptional enhancers that regulate gene expression in neuronal development and might be implicated in neuropsychiatric conditions like Parkinson’s and schizophrenia. The study uncovers new avenues for neuropsychiatric drug development.